Robinhood Plans $200M Public Fund for Y Combinator Startups
Robinhood Ventures Fund II is expected to list on the NYSE at $25 a share, giving retail investors exposure to early-stage private companies tied to Y Combinator.
Archive
Search
Braveheart Bio Targets $1.2 Billion Valuation in IPO
The heart-disease drug developer is seeking up to $318.8 million for clinical trials and research.
Caplight Raises $16 Million for Private-Market Data and Trading Tools
BlackRock and Fin Capital are backing infrastructure that helps investors price, analyze and transact in shares of private companies.
Anthropic Raises $65 Billion at a $965 Billion Valuation
The Claude developer secured one of the largest private financings ever as demand for enterprise AI and computing capacity continues to climb.
Roadrunner Raises $27 Million to Rebuild Quote-to-Cash Software
The young San Francisco company is starting with an AI-assisted alternative to the configuration and approval systems used for complex deals.